What is the Metoject PEN®?
A prefilled autoinjector containing methotrexate (MTX) solution at a concentration of 50mg/ml, indicated for the treatment of:
- Severe recalcitrant disabling psoriasis
- Severe psoriatic arthritis in adult patients
Once prescribed the Metoject PEN®, a patient can be referred for our Metoject at home care service, a unique and complimentary patient centric service, providing:
- 1:1 nurse training in the patient’s home
- sharps waste bin delivered directly to patient’s home
Full details and patient referral information can be found by following this link:
With a heritage of care giving dating back to 1829 we have the track record to support our claims!
Date or preparation: April 2021